Drug Shortage Report for NAT-ERLOTINIB
| Report ID | 129553 |
| Drug Identification Number | 02483939 |
| Brand name | NAT-ERLOTINIB |
| Common or Proper name | Erlotinib Hydrochloride |
| Company Name | NATCO PHARMA (CANADA) INC |
| Market Status | MARKETED |
| Active Ingredient(s) | ERLOTINIB |
| Strength(s) | 150MG |
| Dosage form(s) | TABLET |
| Route of administration | ORAL ORAL |
| Packaging size | Bottle of 30's |
| ATC code | L01XE |
| ATC description | OTHER ANTINEOPLASTIC AGENTS |
| Reason for shortage | Other (Please describe in comments) |
| Anticipated start date | 2020-12-01 |
| Actual start date | 2020-12-01 |
| Estimated end date | 2026-06-30 |
| Actual end date | |
| Shortage status | Actual shortage |
| Updated date | 2024-12-16 |
| Company comments | Long Term Back order |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 2000 ARGENTIA ROAD, PLAZA 1, SUITE 200 MISSISSAUGA, ONTARIO CANADA L5N 1P7 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v13 | 2024-12-16 | French | Compare |
| v12 | 2024-12-16 | English | Compare |
| v11 | 2024-02-02 | French | Compare |
| v10 | 2024-02-02 | English | Compare |
| v9 | 2023-05-03 | French | Compare |
| v8 | 2023-05-03 | English | Compare |
| v7 | 2022-01-17 | English | Compare |
| v6 | 2022-01-17 | French | Compare |
| v5 | 2022-01-17 | English | Compare |
| v4 | 2021-10-14 | French | Compare |
| v3 | 2021-10-14 | English | Compare |
| v2 | 2020-12-03 | French | Compare |
| v1 | 2020-12-03 | English | Compare |
Showing 1 to 13 of 13